Nabla Bio has entered a new multi-year research collaboration with Takeda to advance AI-driven design of protein therapeutics ...

Where training sets were once scraped freely from the web or collected from low-paid annotators, companies are looking to ...

U.S. biotech firm Nabla Bio said on Tuesday it has signed a second major research partnership with Japanese drugmaker Takeda ...

NOD2 deficiency is involved in the pathogenesis of Crohn’s disease (CD) due to failure of gut innate immunity and loss of ...

Cabaletta Bio (CABA) has attracted fresh attention after presenting early data from its RESET-PV clinical trial at the ESGCT Congress. The company reported that its CAR T cell therapy, rese-cel, ...

Here's the thing about training world-class AI models: they're incredibly thirsty. Not for data, well, yes for data, but for ...

An update from Collplant Holdings ( ($CLGN) ) is now available. On October 16, 2025, CollPlant Biotechnologies announced the development of a ...

Nabla Bio partners with Takeda to use its AI platform JAM for designing antibodies, receiving upfront payments and potential ...

Discover how the computational analysis of high-plex imaging can enhance spatial resolution and reproducibility to advance ...

The housing market has stabilized as mortgage rates have stayed below 6.64%, impacting housing demand and inventory.

PollyFab, the forward-thinking innovator in sustainable footwear, takes a decisive leap this season with the Aero and ...

UMass scientists create low-voltage artificial neurons from bacteria that communicate with living cells like real brain cells ...